All Type of News
Who is to assume new KFDA commissioner?
Interest is growing over appointment of the next commissioner of the Korea Food and Drug Administration, as President-elect Lee Myung-bak nominated Kim Sung-i as the next minister of Health and Welfare. Kim is an incu...
Debt to capital ratio of 35 drug makers eased in 2006
The debts to capital ratio of 35 KSE-listed pharmaceutical firms in 2006 averaged 61.0 percent an improvement of 3.5 percentage points from 2005 and their debts totaled 2,805 billion won in 2006, according to dat...
Oriental hospitals should recruit oriental pharmacist
Oriental pharmacists can easily find their jobs in a large oriental hospital, according to the Ministry of Health and Welfare.
Under the newly revised medical law, an oriental hospital that dispense over 160 cases ...
Health insurance re-allowance for ginkgo biloba extracts is slim
Patients taking ginkgo biloba preparations will be unlikely allowed insurance reimbursement as the Ministry of Health and Welfare dispelled the rumors that these products will be reimbursable from this May.
The lea...
Drug wholesalers face hard times
Drug wholesalers are likely to see business setbacks, as the Trade Fair Commission has renewed their efforts to root out irregular business practices, such as the provision of rebates, through its long investigation.
...
Ahngook wins lawsuit over amlodipine
Ahngook Pharm has won the right to market its antihypertensive agent, Levotension (amlopipine besylate S), as the Seoul High Court made its ruling on February 12 that Pfizer's amlodipine patent is null and void, uphol...
Parties yet to agree on drug incentive plan
Lawmakers are to hold discussion over the government's drug incentive bill for doctors who prescribe low-priced drugs as they were unable to iron out their differences on February 14.
Under the bill, doctors will b...
Drug incentive plan plus B2B business will induce illegal rebate
The government plan to introduce the controversial incentive plan for prescription of low-priced drugs, including B2B business, is triggering a backlash from the pharmaceutical industry and drug wholesalers.
The go...
Small drug package system to undergo overhaul
The Korea Food and Drug Administration will unveil its plan to ameliorate the controversial small drug package system, under which drug makers are obliged to produce mall-package drugs as much as 10% of the total outp...
Dong-A's unified distribution policy gains favorable market response
Dong-A Pharmaceutical Co. says its unified distribution policy for its five flagship OTC products has gained good response from wholesalers and pharmacists since last month.
The five products include Panpyrine-Q li...
